Pharmacotherapy Analysis of One Case of Pulmonary Infection Caused by Tropheryma Whipplei

OBJECTIVE  To enhance understanding of antimicrobial therapy for pulmonary infections caused by Tropheryma whipplei.

METHODS  The clinical data of one case of lung mass caused by Tropheryma whipplei in an immunocompetent patient were retrospectively analyzed, and the anti-infective drug treatment plan for lung infection caused by Tropheryma whipplei was analyzed and summarized by reviewing the guidelines and the relevant literature reports in the past three years.

RESULTS After receiving anti-infective treatment with ceftriaxone combined with cotrimoxazole, the patient's condition improved. The patient continued with sequential therapy using cotrimoxazole. Follow-up results showed a significant reduction in the lung mass, indicating that the treatment was effective.

CONCLUSION Lung mass in immunocompetent patients due to Tropheryma whipplei are rare, and the pathogen should be promptly identified and an anti-infective regimen based on ceftriaxone and cotrimoxazole, either as a single agent or in combination, should be used at the earliest possible time.